Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nestor A Molfino

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Expert Opinion on Biological Therapy|April 17, 2012
Targeting of eosinophils in asthmaNestor A Molfino
Medical Hypotheses|November 13, 2009
Increased vagal airway tone in fatal asthmaNestor A Molfino
Expert Review of Respiratory Medicine|August 23, 2013
Recent therapeutic breakthroughs in respiratory medicineNestor A Molfino
International Journal of Chronic Obstructive Pulmonary Disease|November 11, 2008
Gene-environment interactions in chronic obstructive pulmonary diseaseNestor A Molfino, Anthony J Coyle
International Journal of Chronic Obstructive Pulmonary Disease|October 12, 2012
Challenge models to assess new therapies in chronic obstructive pulmonary diseaseRené van der Merwe, Nestor A Molfino
Advances in Therapy|December 19, 2023
Machine Learning Approaches to Predict Asthma Exacerbations: A Narrative ReviewNestor A Molfino, Gianluca Turcatel, Daniel Riskin
Pulmonary Medicine|March 27, 2012
Smoking and idiopathic pulmonary fibrosisChad K Oh, Lynne A Murray, Nestor A Molfino
The Journal of Allergy and Clinical Immunology. in Practice|January 22, 2023
Toward a Predict and Prevent Approach in Obstructive Airway DiseasesSimon Couillard, Nayia Petousi, Kate S Smigiel, et al.
Inflammation & Allergy Drug Targets|March 25, 2011
Biology of the interleukin-9 pathway and its therapeutic potential for the treatment of asthmaChad K Oh, Donald Raible, Gregory P Geba, et al.
BMC Pulmonary Medicine|January 13, 2010
A phase 1 study evaluating the pharmacokinetics, safety and tolerability of repeat dosing with a human IL-13 antibody (CAT-354) in subjects with asthmaDave Singh, Binita Kane, Nestor A Molfino, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Expert Opinion on Biological Therapy|April 17, 2012
Targeting of eosinophils in asthmaNestor A Molfino
Medical Hypotheses|November 13, 2009
Increased vagal airway tone in fatal asthmaNestor A Molfino
Expert Review of Respiratory Medicine|August 23, 2013
Recent therapeutic breakthroughs in respiratory medicineNestor A Molfino
International Journal of Chronic Obstructive Pulmonary Disease|November 11, 2008
Gene-environment interactions in chronic obstructive pulmonary diseaseNestor A Molfino, Anthony J Coyle
International Journal of Chronic Obstructive Pulmonary Disease|October 12, 2012
Challenge models to assess new therapies in chronic obstructive pulmonary diseaseRené van der Merwe, Nestor A Molfino
Advances in Therapy|December 19, 2023
Machine Learning Approaches to Predict Asthma Exacerbations: A Narrative ReviewNestor A Molfino, Gianluca Turcatel, Daniel Riskin
Pulmonary Medicine|March 27, 2012
Smoking and idiopathic pulmonary fibrosisChad K Oh, Lynne A Murray, Nestor A Molfino
The Journal of Allergy and Clinical Immunology. in Practice|January 22, 2023
Toward a Predict and Prevent Approach in Obstructive Airway DiseasesSimon Couillard, Nayia Petousi, Kate S Smigiel, et al.
Inflammation & Allergy Drug Targets|March 25, 2011
Biology of the interleukin-9 pathway and its therapeutic potential for the treatment of asthmaChad K Oh, Donald Raible, Gregory P Geba, et al.
BMC Pulmonary Medicine|January 13, 2010
A phase 1 study evaluating the pharmacokinetics, safety and tolerability of repeat dosing with a human IL-13 antibody (CAT-354) in subjects with asthmaDave Singh, Binita Kane, Nestor A Molfino, et al.
Pageof 4